Home > products > custom-nanocomposites
> fluorescent-labeled-nanocomposites
> dops-dopc-chol-dope-n-dbco-20-49-30-1-molar-ratio-based-fluoroliposome-dio-dbco
DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiO-DBCO
1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt):1,2-dioleoyl-sn-glycero-3-phosphocholine:Cholesterol:1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-dibenzocyclooctyl(20:49:30:1molar ratio)-based Fluoroliposome DiO-DBCO
Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
---|---|---|---|---|
R-Mcs-230 | 1EA | inquiry | ||
|
Product description
DOPS:DOPC:Chol:DOPE-N-DBCO(20:49:30:1molar ratio)-based Fluoroliposome DiO-DBCO can encapsulate therapeutic agents, allowing for targeted and controlled drug delivery in oncology or other therapeutic applications.The fluorescent nature of DiO allows for visualization of the liposomes in biological systems, facilitating tracking of their distribution and uptake in cells.The DBCO functionalization enables the attachment of various biomolecules, which can help in specific targeting against disease markers or deliver imaging probes.Due to the presence of DOPS, these liposomes can facilitate immune responses and be harnessed in vaccine formulations.
Appearance | N/A |
---|---|
DOPS:DOPC:Chol:DOPE-N-DBCO | 20:49:30:1molar ratio |
DiO-Excitation/Emission | 484/501nm |
Liposome Size | 100 nm |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 3 weeks |
Stability | 1 year |
Document
Related Product